ALPS Advisors
VERA icon

ALPS Advisors’s Vera Therapeutics VERA Stock Holding History

ALPS Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.08M Buy
95,495
+22,938
+32% +$802K 0.01% 397
2026
Q2 		$3.11M Buy
72,557
+14,470
+25% +$539K 0.01% 390
2026
Q1 		$2.34M Buy
58,087
+5,695
+11% +$245K 0.01% 375
2025
Q4 		$2.65M Buy
52,392
+21,642
+70% +$769K 0.02% 348
2025
Q3 		$894K Sell
30,750
-3,691
-11% -$85.4K 0.01% 555
2025
Q2 		$811K Sell
34,441
-12,071
-26% -$271K ﹤0.01% 564
2025
Q1 		$1.12M Sell
46,512
-4,695
-9% -$151K 0.01% 453
2024
Q4 		$2.17M Buy
51,207
+6,941
+16% +$307K 0.01% 338
2024
Q3 		$1.96M Buy
44,266
+1,432
+3% +$54.3K 0.01% 363
2024
Q2 		$1.55M Buy
42,834
+4,102
+11% +$163K 0.01% 376
2024
Q1 		$1.67M Buy
38,732
+8,512
+28% +$303K 0.01% 381
2023
Q4 		$465K Sell
30,220
-2,490
-8% -$31.6K ﹤0.01% 617
2023
Q3 		$448K Buy
32,710
+175
+0.5% +$3K ﹤0.01% 611
2023
Q2 		$522K Buy
32,535
+4,906
+18% +$44.3K ﹤0.01% 608
2023
Q1 		$214K Buy
27,629
+8,880
+47% +$68.5K ﹤0.01% 979
2022
Q4 		$363K Buy
18,749
+4,005
+27% +$72.5K ﹤0.01% 720
2022
Q3 		$314K Sell
14,744
-1,316
-8% -$24.6K ﹤0.01% 708
2022
Q2 		$219K Buy
+16,060
New +$280K ﹤0.01% 980

Other funds holding VERA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

ALPS Advisors's VERA Position: Q3 2026 in Review

ALPS Advisors increased its Vera Therapeutics (VERA) stake by 32% in Q3 2026, buying an estimated $802K and bringing the position to 95,495 shares worth $3.08M. The position accounts for 0.01% of the portfolio, ranked #397.

ALPS Advisors first reported a position in VERA in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.11M in Q2 2026. 49 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • ALPS Advisors held 95,495 shares of Vera Therapeutics worth $3.08M as of Q3 2026.
  • ALPS Advisors bought 22,938 Vera Therapeutics shares in Q3 2026, an estimated $802K.
  • Vera Therapeutics made up 0.01% of ALPS Advisors's portfolio in Q3 2026, its #397 holding.
  • ALPS Advisors first reported a position in Vera Therapeutics in Q2 2022 and has held it in 18 quarters since.
  • ALPS Advisors's Vera Therapeutics position peaked at $3.11M in Q2 2026.
  • 49 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.